Preliminary experimental animal study on reducing 223Ra gastrointestinal radiation injury by EDTA complexation in vivo
NUCLEAR CHEMISTRY, RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE|更新时间:2024-10-25
|
Preliminary experimental animal study on reducing 223Ra gastrointestinal radiation injury by EDTA complexation in vivo
“In the field of tumor bone metastasis treatment, researchers have found that intravenous injection of EDTA can effectively promote the clearance of 223RaCl2 in the gastrointestinal tract and reduce radiation damage.”
LI Danni, female, born in 1993, graduated from Xuzhou Medical University with a master's degree in 2019, focusing on theranostics in nuclear medicine
PENG Ye, E-mail: pengye4201985@163.com
ZUO Changjing, E-mail: changjing.zuo@qq.com
基金信息:
Shanghai "Rising Stars of Medical Talent" Youth Development Program (SHWRS(2020)_087), the "Discipline Construction Climbing 234 Plan" of Changhai Hospital of Naval Medical University (Second Military Medical University)(沪卫人事[2020]087号);Advanced Appropriate Technology Promotion Project of Shanghai Municipal Health Commission(2019YPT002;2020YPT002)
LI Danni,LI Xiao,YANG Jian,et al.Preliminary experimental animal study on reducing 223Ra gastrointestinal radiation injury by EDTA complexation in vivo[J].NUCLEAR TECHNIQUES,2022,45(04):040301-040301.
LI Danni,LI Xiao,YANG Jian,et al.Preliminary experimental animal study on reducing 223Ra gastrointestinal radiation injury by EDTA complexation in vivo[J].NUCLEAR TECHNIQUES,2022,45(04):040301-040301. DOI: 10.11889/j.0253-3219.2022.hjs.45.040301.
Preliminary experimental animal study on reducing 223Ra gastrointestinal radiation injury by EDTA complexation in vivo